Iperplasia diffusa delle cellule polmonari neuroendocrine (DIPNECH): diagnosi e gestione clinica

No abstract is available for this paper.

• Publication year

  2025

• Venue

  L Endocrinologo

• Publication date

  2025-09-02

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s40619-025-01685-y
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Investigating pulmonary neuroendocrine cells in human respiratory diseases with airway models

  2024cited by this paper
• Diagnostic Anatomic Imaging for Neuroendocrine Neoplasms: Maximizing Strengths and Mitigating Weaknesses

  2024cited by this paper
• A multidisciplinary approach to the work up and management of pulmonary carcinoid tumors and DIPNECH: a narrative review

  2021cited by this paper
• Somatostatin analogs (SSA) improve respiratory symptoms in patients with diffuse idiopathic neuroendocrine cell hyperplasia (DIPNECH).

  2020cited by this paper
• Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Imaging and Clinical Features of a Frequently Delayed Diagnosis.

  2020influential reference
• Pulmonary neuroendocrine cells: physiology, tissue homeostasis and disease

  2020cited by this paper
• Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome

  2016influential reference
• Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a systematic overview.

  2011influential reference
• Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

  2007cited by this paper
• Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease

  2006cited by this paper
• The new World Health Organization classification of lung tumours

  2001cited by this paper
• Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease.

  1992cited by this paper

• No citing papers are available for this paper.